Browsing Pharmacy Research by Subject "abemaciclib"

Now showing items 1-1 of 1

Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation

Elazzazy, Shereen; Al-Ziftawi, Nour Hisham; Mohamed Ibrahim, Mohamed Izham; Bujassoum, Salha; Hamad, Anas ( Frontiers Media S.A. , 2024 , Article)
Introduction: CDK4/6 inhibitors are the first-line treatment for HR+/HER2- advanced breast cancer. Despite their clinical benefit, they can increase healthcare expenditure. To date, there is no thorough comparison among ...